CoChat

Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York

Open access
West, Anthony P., Wertheim, Joel O., Wang, Jade C., Vasylyeva, Tetyana I., Havens, Jennifer L., Chowdhury, Moinuddin A., Gonzalez, Edimarlyn, Fang, Courtney E., Di Lonardo, Steve S., Hughes, Scott, Rakeman, Jennifer L., Lee, Henry H., Barnes, Christopher O., Gnanapragasam, Priyanthi N. P., Yang, Zhi, Gaebler, Christian, Caskey, Marina, Nussenzweig, Michel C., Keeffe, Jennifer R., Bjorkman, Pamela J. · 2021 · Nature Communications

Published version of a preprint

Cited by 89

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Wide-scale SARS-CoV-2 genome sequencing is critical to tracking viral evolution during the ongoing pandemic. We develop the software tool, Variant Database (VDB), for quickly examining the changing landscape of spike mutations. Using VDB, we detect an emerging lineage of SARS-CoV-2 in the New York region that shares mutations with previously reported variants. The most common sets of spike mutations in this lineage (now designated as B.1.526) are L5F, T95I, D253G, E484K or S477N, D614G, and A701V. This lineage was first sequenced in late November 2020. Phylodynamic inference confirmed the rapid growth of the B.1.526 lineage. In concert with other variants, like B.1.1.7, the rise of B.1.526 appears to have extended the duration of the second wave of COVID-19 cases in NYC in early 2021. Pseudovirus neutralization experiments demonstrated that B.1.526 spike mutations adversely affect the neutralization titer of convalescent and vaccinee plasma, supporting the public health relevance of this lineage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-021-25168-4

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 20

  1. Hodcroft, E. B. et al. Want to track pandemic variants faster? Fix the bioinformatics bottleneck. Nature 591, 30–33 (2021). · DOI
  2. Shu, Y. & McCauley, J. GISAID: global initiative on sharing all influenza data—from vision to reality. Euro. Surveill. 22, 30494 (2017). · DOI · Paper page
  3. Chen, J., Wang, R., Wang, M. & Wei, G.-W. Mutations Strengthened SARS-CoV-2 Infectivity. J. Mol. Biol. 432, 5212–5226 (2020). · DOI · Paper page
  4. Ou, J. et al. Emergence of SARS-CoV-2 spike RBD mutants that enhance viral infectivity through increased human ACE2 receptor binding affinity. bioRxiv. Preprint at https://doi.org/10.1101/2020.03.15.991844 (2020). · DOI
  5. Suchard, M. A. et al. Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol. 4, vey016 (2018). · DOI · Paper page
  6. Muecksch, F. et al. Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity https://doi.org/10.1016/j.immuni.2021.07.008. (2021). · DOI · Paper page
  7. Vavrek, D. et al. Genomic surveillance at scale is required to detect newly emerging strains at an early timepoint. medrxiv. Preprint at https://doi.org/10.1101/2021.01.12.21249613 (2021). · DOI
  8. Lasek-Nesselquist, E., Lapierre, P., Schneider, E., George, K. St. & Pata, J. The localized rise of a B.1.526 SARS-CoV-2 variant containing an E484K mutation in New York State. medrxiv. Preprint at https://doi.org/10.1101/2021.02.26.21251868 (2021). · DOI
  9. Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772–780 (2013). · DOI · Paper page
  10. Letunic, I. & Bork, P. Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics 23, 127–128 (2007). · DOI · Paper page
  11. Tyson, J. R. et al. Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore. bioRxiv. Preprint at https://doi.org/10.1101/2020.09.04.283077 (2020). · DOI · Paper page
  12. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754–1760 (2009). · DOI · Paper page
  13. Grubaugh, N. D. et al. An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar. Genome Biol. 20, 8 (2019). · DOI · Paper page
  14. Li, H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics 27, 2987–2993 (2011). · DOI · Paper page
  15. Freed, N. E., Vlková, M., Faisal, M. B. & Silander, O. K. Rapid and inexpensive whole-genome sequencing of SARS-CoV-2 using 1200 bp tiled amplicons and Oxford Nanopore Rapid Barcoding. Biol. Methods Protoc. 5, bpaa014 (2020). · DOI · Paper page
  16. Wu, W. Y., Jiang, Q. & Di Lonardo, S. S. Poorly controlled diabetes in New York City: mapping high-density neighborhoods. J. Public Health Manag. Pract. 24, 69–74 (2018). · DOI
  17. Sagulenko, P., Puller, V. & Neher, R. A. TreeTime: maximum-likelihood phylodynamic analysis. Virus Evol. 4, vex042 (2018). · DOI · Paper page
  18. Cohen, A. A. et al. Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice. Science 371, 735–741 (2021). · DOI · Paper page
  19. Crawford, K. H. D. et al. Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays. Viruses 12, 513 (2020). · DOI · Paper page
  20. West, A. P. et al. Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues. Proc. Natl Acad. Sci. USA 110, 10598–10603 (2013). · DOI

Cited by

See all 89

Metadata

Authors
West, A. P., Wertheim, J. O., Wang, J. C., Vasylyeva, T. I., Havens, J. L., Chowdhury, M. A., Gonzalez, E., Fang, C. E., Di Lonardo, S. S., Hughes, S., Rakeman, J. L., Lee, H. H., Barnes, C. O., Gnanapragasam, P. N. P., Yang, Z., Gaebler, C., Caskey, M., Nussenzweig, M. C., Keeffe, J. R., & Bjorkman, P. J.
Venue
Nature Communications
Published
2021-08-09
Volume
12
Issue
1
Pages
4886-4886
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3189449818
Cited by
89
References
23
FWCI
6.14
Type
journal article
Language
en
Open access
gold
Licence
Funders
  • Bill and Melinda Gates Foundation (INV-002143)
  • Caltech Merkin Institute for Translational Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York. https://app.cochat.ai/papers/10.1038/s41467-021-25168-4
The paper
West, A. P., Wertheim, J. O., Wang, J. C., Vasylyeva, T. I., Havens, J. L., Chowdhury, M. A., Gonzalez, E., Fang, C. E., Di Lonardo, S. S., Hughes, S., Rakeman, J. L., Lee, H. H., Barnes, C. O., Gnanapragasam, P. N. P., Yang, Z., Gaebler, C., Caskey, M., Nussenzweig, M. C., Keeffe, J. R., & Bjorkman, P. J. (2021). Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York. Nature Communications. https://doi.org/10.1038/s41467-021-25168-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.